Cancer Patients With Breakthrough COVID-19 Remain at Risk for Severe Outcomes
MONDAY, Dec. 27, 2021 -- Patients with cancer who develop breakthrough infection following COVID-19 vaccination remain at risk for severe outcomes, according to a study published online Dec. 24 in the Annals of Oncology.
Andrew L. Schmidt, M.B.,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | COVID-19 | Pharmaceuticals | Study | Vaccines